December 12, 2013
We continue to incorporate patient and customer feedback into our innovation pathway, and are excited to now include separately packaged Angel Wings™ adhesive pads with each VasoStat™ Hemostasis Device. Angel Wings™ deliver just what our customers were looking for: a... Read more
June 1, 2013
Forge Medical, Inc., a Pennsylvania-based medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the VasoStat(TM) Hemostasis Device to promote hemostasis following vascular catheterization, including radial artery catheterization, arterial or venous line removal, hemodialysis, and vascular punctures in patients receiving anticoagulation therapy.
April 1, 2013
We are pleased to be exhibiting our enhanced VasoStat™ at the ANNA Annual Meeting in Las Vegas. We've been extremely pleased from the feedback we've received to date about the VasoStat™ from nephrology nurses, physicians, and most importantly of all, our patients. We have incorporated patient and customer feedback into our innovation pathway, and we are excited to offer an even improved version of the VasoStat™ as a solution to puncture site hemostasis which avoids the concerns of cross contamination, nonadjustable puncture site pressure, and unnecessary time demands on nephrology health care professionals.
September 2, 2012
Philadelphia, PA, USA (September 2, 2012) – Forge Medical, Inc., a Pennsylvania-based medical device company, will exhibit its novel dialysis hemostasis device at the American Nephrology Nurses’ Association 2012 Fall Meeting on September 28-30, 2012 in Chicago, IL followed by a limited market release in several key dialysis clinics in the United States.
March 1, 2012
By Laurie K. Dickinson, RN, BSN, and Timothy W.I. Clark, MD